EE376 Estimated Financial Impact of the Drug Cladribine Incorporation for the Relapsing-Remitting Multiple Sclerosis Treatment (RRMS) in a Health Insurance Company in Brazil
Abstract
Authors
J.M. Alves Junior F.E. Prota J.C.B. Martinelli A. Chrispim M. Serpeloni Christoforo Barreto F.F II, B.M. Nascimento M.M. Ferreira